Product recalls in the life sciences industry are not rare. In Q1 2018 alone, for example, 84 pharmaceutical companies in the U.S. reported at least one recall. While these recalls are often attributed to defective or potentially harmful drugs (such was the case in the infamous 1982 recall of 31 million bottles of Tylenol tainted […]

Generative AI, a subset of artificial intelligence that analyzes large volumes of data to create text, images, and other outputs, is quickly becoming a disruptive force in the life sciences industry. For example, this purpose-built technology is employed to accelerate drug discovery, improve clinical trial planning and execution, decrease drug recalls, and lead to more […]